NO171214C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater

Info

Publication number
NO171214C
NO171214C NO891650A NO891650A NO171214C NO 171214 C NO171214 C NO 171214C NO 891650 A NO891650 A NO 891650A NO 891650 A NO891650 A NO 891650A NO 171214 C NO171214 C NO 171214C
Authority
NO
Norway
Prior art keywords
pyridon
preparation
carboxylic acid
acid derivatives
therapeutic active
Prior art date
Application number
NO891650A
Other languages
English (en)
Norwegian (no)
Other versions
NO891650L (no
NO171214B (no
NO891650D0 (no
Inventor
Hirokazu Narita
Yozo Todo
Jun Nitta
Hiroyasu Takagi
Fumihiko Iino
Mikako Miyajima
Yoshikazu Fukuoka
Isamu Saikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NO891650D0 publication Critical patent/NO891650D0/no
Publication of NO891650L publication Critical patent/NO891650L/no
Publication of NO171214B publication Critical patent/NO171214B/no
Publication of NO171214C publication Critical patent/NO171214C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
NO891650A 1988-04-23 1989-04-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater NO171214C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10062888 1988-04-23
JP1075873A JPH0228178A (ja) 1988-04-23 1989-03-28 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法

Publications (4)

Publication Number Publication Date
NO891650D0 NO891650D0 (no) 1989-04-21
NO891650L NO891650L (no) 1989-10-24
NO171214B NO171214B (no) 1992-11-02
NO171214C true NO171214C (no) 1993-02-10

Family

ID=26417038

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891650A NO171214C (no) 1988-04-23 1989-04-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater

Country Status (21)

Country Link
US (1) US4990508A (de)
JP (1) JPH0228178A (de)
KR (1) KR910005833B1 (de)
AT (1) AT398422B (de)
AU (1) AU601324B2 (de)
BE (1) BE1003252A4 (de)
CA (1) CA1340493C (de)
CH (1) CH680793A5 (de)
DE (1) DE3913245C2 (de)
DK (1) DK175649B1 (de)
ES (1) ES2016012A6 (de)
FI (1) FI91529C (de)
FR (1) FR2630441B1 (de)
GB (1) GB2217710B (de)
HU (2) HU205759B (de)
IL (1) IL89931A (de)
IT (1) IT1231760B (de)
NL (1) NL192832C (de)
NO (1) NO171214C (de)
NZ (1) NZ228847A (de)
SE (1) SE504625C2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104868A (en) * 1988-06-21 1992-04-14 Pfizer Inc. Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
EP0366189A3 (de) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Antimikrobielle Lactam-Quinolone
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
IT1248011B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Procedimento per la preparazione dell'acido 9-fluoro-10- (4-metil-1-piperazinil)-7-oxo-2,3-diidro-7h-pirido (1,2,3-de) (1,4)benzotiadin-6-carbossilico cloridrato.
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
TW252107B (de) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
IT1270836B (it) * 1993-10-27 1997-05-13 Archimica Spa Procedimento per la preparazione di rufloxacina e suoi sali
IT1270834B (it) * 1993-10-27 1997-05-13 Archimica Spa Disolfuro chinolico
USH1480H (en) * 1993-12-09 1995-09-05 The Procter & Gamble Company Methods of using dyphylline for the promotion of hair growth
CA2367373C (en) 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
EA008889B1 (ru) 2002-03-21 2007-08-31 Басф Акциенгезельшафт Фунгицидные триазолопиримидины, способ их получения и их применение для борьбы с фитопатогенными грибами, а также содержащие их средства
CN1332962C (zh) * 2005-07-12 2007-08-22 武汉人福药业有限责任公司 一种合成甲磺酸帕珠沙星中间体的方法
KR101419554B1 (ko) * 2006-03-13 2014-07-17 교린 세이야꾸 가부시키 가이샤 Ｇｓｋ­３ 억제제로서 아미노퀴놀론
JP5426552B2 (ja) * 2007-09-11 2014-02-26 杏林製薬株式会社 Ｇｓｋ−３阻害剤としてのシアノアミノキノロン及びテトラゾロアミノキノロン
US8476261B2 (en) 2007-09-12 2013-07-02 Kyorin Pharmaceutical Co., Ltd. Spirocyclic aminoquinolones as GSK-3 inhibitors
EP2406266B1 (de) * 2009-03-11 2013-12-25 Kyorin Pharmaceutical Co., Ltd. 7-cycloalkylaminochinolone als gsk-3-hemmer
CN101928290B (zh) * 2009-11-27 2011-11-09 浙江司太立制药股份有限公司 一种甲磺酸帕珠沙星的纯化方法
CN102295652A (zh) * 2011-06-27 2011-12-28 辽宁海神联盛制药有限公司 一种甲磺酸帕珠沙星合成工艺的改进方法
CN102850375A (zh) * 2012-03-06 2013-01-02 江西师范大学 一类多取代吡啶并[4, 3-d]噁嗪化合物及制备方法
CN103772412B (zh) * 2012-10-23 2016-03-16 浙江海森药业有限公司 一种帕珠沙星中间体的制备方法
CN105622632B (zh) * 2014-10-29 2018-06-29 浙江海森药业股份有限公司 一种喹诺酮类化合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883522A (en) * 1974-02-11 1975-05-13 Riker Laboratories Inc Substituted pyrido(1,2,3-de)-1,4-benzoxazines
DE3211984C2 (de) * 1981-05-21 1986-04-03 Dieter Dr. 7900 Ulm Benz Rotierende Zahnbürste
JPS591489A (ja) * 1982-06-29 1984-01-06 Dai Ichi Seiyaku Co Ltd ピリドベンゾオキサジン誘導体
DE3234529A1 (de) * 1982-09-17 1984-03-22 Bayer Ag, 5090 Leverkusen Substituierte benzoxazin-derivate
US4603199A (en) * 1982-10-25 1986-07-29 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agent intermediates
US4540694A (en) * 1984-04-26 1985-09-10 Abbott Laboratories 1-Pyridine substituted quino-benoxazines and antibacterial use
US4607032A (en) * 1984-04-26 1986-08-19 Abbott Laboratories Quino-benoxazine antibacterial compounds
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
DE3522406A1 (de) * 1985-06-22 1987-01-02 Bayer Ag Verfahren zur herstellung von 1,8-verbrueckten 4-chinolon-3-carbonsaeuren
DE3522405A1 (de) * 1985-06-22 1987-01-02 Bayer Ag 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3543513A1 (de) * 1985-12-10 1987-06-11 Bayer Ag Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
US4777253A (en) * 1986-04-25 1988-10-11 Abbott Laboratories Process for preparation of racemate and optically active ofloxacin and related derivatives
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
DE3623757A1 (de) * 1986-07-15 1988-01-21 Bayer Ag Neue 1,8-verbrueckte 4-chinoloncarbonsaeuren und diese enthaltende arzneimittel
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
DE3641661A1 (de) * 1986-12-05 1988-06-30 Bayer Ag Verfahren zur herstellung von chinoloncarbonsaeureestern
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JP2598921B2 (ja) * 1987-10-05 1997-04-09 富山化学工業株式会社 新規なキノリン誘導体およびその塩
DE3810080A1 (de) * 1988-03-25 1989-10-05 Bayer Ag Trisubstituierte 1,3,5-triazin-2,4,6-trione
DE3815481A1 (de) * 1988-05-06 1989-11-16 Sandoz Ag Sulfonsaeuregruppenfreie basische verbindung
US5039682A (en) * 1988-06-21 1991-08-13 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor

Also Published As

Publication number Publication date
NZ228847A (en) 1990-04-26
GB2217710A (en) 1989-11-01
NL8901007A (nl) 1989-11-16
NO891650L (no) 1989-10-24
DE3913245C2 (de) 1999-07-15
FI891910A0 (fi) 1989-04-21
DK192589D0 (da) 1989-04-20
FI91529B (fi) 1994-03-31
FI91529C (fi) 1994-07-11
IT1231760B (it) 1991-12-21
ES2016012A6 (es) 1990-10-01
FR2630441B1 (fr) 1994-10-14
IL89931A (en) 1993-06-10
AT398422B (de) 1994-12-27
CA1340493C (en) 1999-04-13
JPH0588714B2 (de) 1993-12-24
BE1003252A4 (fr) 1992-02-11
AU601324B2 (en) 1990-09-06
SE504625C2 (sv) 1997-03-17
US4990508A (en) 1991-02-05
IT8947875A0 (it) 1989-04-21
ATA95989A (de) 1994-04-15
AU3266189A (en) 1989-10-26
HU211568A9 (en) 1995-12-28
DK175649B1 (da) 2005-01-03
DK192589A (da) 1989-10-24
GB2217710B (en) 1991-12-04
DE3913245A1 (de) 1989-11-02
HU205759B (en) 1992-06-29
FR2630441A1 (fr) 1989-10-27
NL192832B (nl) 1997-11-03
NL192832C (nl) 1998-03-04
FI891910A (fi) 1989-10-24
SE8901464L (sv) 1989-10-24
IL89931A0 (en) 1989-12-15
GB8908096D0 (en) 1989-05-24
HUT51621A (en) 1990-05-28
CH680793A5 (de) 1992-11-13
KR900016222A (ko) 1990-11-12
SE8901464D0 (sv) 1989-04-21
NO171214B (no) 1992-11-02
KR910005833B1 (ko) 1991-08-05
NO891650D0 (no) 1989-04-21
JPH0228178A (ja) 1990-01-30

Similar Documents

Publication Publication Date Title
NO171214C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
NO169439C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler
NO171209C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfinanestere
NO172048C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoler
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO173238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO864425L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater
NO172986C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 9h-puriner
NO893270D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
NO902710L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater.
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
NO170930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-okso-3-kinolinkarboksylsyrer
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO175476C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive cykloalkyltiazolderinvater
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.

Legal Events

Date Code Title Description
MK1K Patent expired